Patents Assigned to MedGene Ltd.
  • Publication number: 20100135997
    Abstract: The present invention provides monomeric and dimeric polypeptide fusions comprising mutated human ILT molecules and immunoglobulin Fc segments. Such compostions are useful, either alone or associated with a therapeutic agent, for targeting cells expressing Class I pMHC molecules.
    Type: Application
    Filed: November 8, 2007
    Publication date: June 3, 2010
    Applicant: MedGene Ltd.
    Inventors: Bent Karsten Jakobsen, Yi Li, Ruth Karen Moysey